1. Home
  2. GOCO vs LUNG Comparison

GOCO vs LUNG Comparison

Compare GOCO & LUNG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GOCO
  • LUNG
  • Stock Information
  • Founded
  • GOCO 2001
  • LUNG 1995
  • Country
  • GOCO United States
  • LUNG United States
  • Employees
  • GOCO N/A
  • LUNG N/A
  • Industry
  • GOCO Specialty Insurers
  • LUNG Industrial Specialties
  • Sector
  • GOCO Finance
  • LUNG Health Care
  • Exchange
  • GOCO Nasdaq
  • LUNG Nasdaq
  • Market Cap
  • GOCO 64.9M
  • LUNG 65.6M
  • IPO Year
  • GOCO 2020
  • LUNG 2020
  • Fundamental
  • Price
  • GOCO $4.98
  • LUNG $1.70
  • Analyst Decision
  • GOCO Hold
  • LUNG Buy
  • Analyst Count
  • GOCO 1
  • LUNG 7
  • Target Price
  • GOCO $12.00
  • LUNG $7.66
  • AVG Volume (30 Days)
  • GOCO 44.9K
  • LUNG 570.9K
  • Earning Date
  • GOCO 11-06-2025
  • LUNG 10-29-2025
  • Dividend Yield
  • GOCO N/A
  • LUNG N/A
  • EPS Growth
  • GOCO N/A
  • LUNG N/A
  • EPS
  • GOCO N/A
  • LUNG N/A
  • Revenue
  • GOCO $822,444,000.00
  • LUNG $90,549,000.00
  • Revenue This Year
  • GOCO $4.66
  • LUNG $10.30
  • Revenue Next Year
  • GOCO $6.95
  • LUNG $14.72
  • P/E Ratio
  • GOCO N/A
  • LUNG N/A
  • Revenue Growth
  • GOCO 17.46
  • LUNG 18.24
  • 52 Week Low
  • GOCO $4.65
  • LUNG $1.47
  • 52 Week High
  • GOCO $21.00
  • LUNG $9.37
  • Technical
  • Relative Strength Index (RSI)
  • GOCO 42.52
  • LUNG 43.79
  • Support Level
  • GOCO $4.65
  • LUNG $1.60
  • Resistance Level
  • GOCO $4.98
  • LUNG $1.80
  • Average True Range (ATR)
  • GOCO 0.27
  • LUNG 0.14
  • MACD
  • GOCO -0.00
  • LUNG 0.04
  • Stochastic Oscillator
  • GOCO 34.18
  • LUNG 36.67

About GOCO GoHealth Inc.

GoHealth Inc is a health insurance marketplace and Medicare-focused digital health company whose purpose is to compassionately ensure consumers' peace of mind when making healthcare decisions so consumers can focus on living life. It offers Medicare plans, including, but not limited to, Medicare Advantage, Medicare Supplement and prescription drug plans. Its proprietary technology platform leverages modern machine-learning algorithms, powered by over two decades of insurance purchasing behavior, to reimagine the process of matching a health plan to a consumer's specific needs.

About LUNG Pulmonx Corporation

Pulmonx Corp is a commercial-stage medical technology company. It provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease (COPD). The company's solutions are comprised of the Zephyr Endobronchial Valve, the Chartis Pulmonary Assessment System and the StratX Lung Analysis Platform. It generates revenue through the sale of products to distributors and hospitals in the United States which a key revenue generating market, Europe, Middle-East and Africa, Asia Pacific and other regions.

Share on Social Networks: